Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Yasufumi Kawasaki, MD PhD, Kazuya Sato, MDPhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2018-99-111773

Published: 2018

Journal Articles

CCL3 Signaling Is Essential for Leukemia Progression but Dispensable for Hematopoietic Stem Cell Maintenance

Rhonda J. Staversky, BS, Mary A Georger, B.S., Marian Ackun-Farmmer, B.S., Michael W. Becker, MD, Danielle S.W. Benoit, PhD, Laura M. Calvi, MD, Benjamin J. Frisch, PhD

Blood (2017) 130 (Supplement 1): 2603.

https://doi.org/10.1182/blood.V130.Suppl_1.2603.2603

Published: 2017

Journal Articles

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Ryan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang, James A. Hoxie, Rosemarie Mick, Stephen G. Emerson, Yi Zhang, Robert H. Vonderheide, David L. Porter, Ran Reshef

Blood (2017) 129 (7): 906–916.

https://doi.org/10.1182/blood-2016-08-735076

Published: 2017

Includes: Supplemental data

Journal Articles

CCL5 derived from platelets increases megakaryocyte proplatelet formation

Kellie R. Machlus, Kelly E. Johnson, Rajesh Kulenthirarajan, Jodi A. Forward, Mason D. Tippy, Thomas S. Soussou, Saleh H. El-Husayni, Stephen K. Wu, Suming Wang, Randolph S. Watnick, Joseph E. Italiano, Jr, Elisabeth M. Battinelli

Blood (2016) 127 (7): 921–926.

https://doi.org/10.1182/blood-2015-05-644583

Published: 2016

Journal Articles

Platelets Promote Breast Cancer Metastasis By Reprogramming Tumor Cells to Produce IL-8

Kelly Elizabeth Johnson, PhD, Kellie R Machlus, PhD, Saleh El-Husayni, Rajesh Kulenthirarajan, Jodi A Forward, Joseph E Italiano, Jr., PhD, Elisabeth M. Battinelli, MD PhD

Blood (2015) 126 (23): 2233.

https://doi.org/10.1182/blood.V126.23.2233.2233

Published: 2015

Journal Articles

CCL5 Released from Platelets Increases Megakaryocyte Maturation and Proplatelet Formation

Kellie R Machlus, PhD, Kelly Elizabeth Johnson, PhD, Rajesh Kulenthirarajan, Saleh El-Husayni, Jodi A Forward, Stephen K Wu, Joseph E Italiano, Jr., PhD, Elisabeth M. Battinelli, MD PhD

Blood (2015) 126 (23): 1162.

https://doi.org/10.1182/blood.V126.23.1162.1162

Published: 2015

Journal Articles

Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis

Ryan H Moy, MD PhD, Austin P Huffman, BA, Lee P Richman, BA, Lisa Crisalli, BS, James A Hoxie, MD, Robert H Vonderheide, MD DPhil, David L Porter, MD, Ran Reshef, MD

Blood (2015) 126 (23): 920.

https://doi.org/10.1182/blood.V126.23.920.920

Published: 2015

Journal Articles

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Ran Reshef, MD, James K. Mangan, MDPhD, Selina M. Luger, MD, Alison Wakoff Loren, MDMS, Elizabeth O. Hexner, MD, Noelle V. Frey, MDMS, Edward A. Stadtmauer, MD, Robin E. Blauser, BSN RN, Lee P. Richman, BA, Austin P. Huffman, BA, Alex Ganetsky, PharmD, Edward P. Acosta, PharmD, James A. Hoxie, MD, Rosemarie Mick, MS, Robert H. Vonderheide, MDDPhil, David L. Porter, MD

Blood (2014) 124 (21): 2491.

https://doi.org/10.1182/blood.V124.21.2491.2491

Published: 2014

Journal Articles

Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals

Christina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, Selma Trabelsi, Jade Ghosn, Caroline Lascoux-Combe, Philippe Flandre, Lise Cuzin, Jacques Reynes, Brigitte Autran, Pierre Corbeau

Blood (2013) 122 (13): 2282–2283.

https://doi.org/10.1182/blood-2013-06-507012

Published: 2013

Journal Articles

Response: maraviroc intensification and microbial translocation

Peter W. Hunt, Michael M. Lederman, Steven G. Deeks

Blood (2013) 122 (13): 2283–2284.

https://doi.org/10.1182/blood-2013-08-516930

Published: 2013

Journal Articles

The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial

Peter W. Hunt, Nancy S. Shulman, Timothy L. Hayes, Viktor Dahl, Ma Somsouk, Nicholas T. Funderburg, Bridget McLaughlin, Alan L. Landay, Oluwatoyin Adeyemi, Lee E. Gilman, Brian Clagett, Benigno Rodriguez, Jeffrey N. Martin, Timothy W. Schacker, Barbara L. Shacklett, Sarah Palmer, Michael M. Lederman, Steven G. Deeks

Blood (2013) 121 (23): 4635–4646.

https://doi.org/10.1182/blood-2012-06-436345

Published: 2013

Includes: Supplemental data

Journal Articles

Defining the Primate GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus

Natalia Kozyr, Ph.D., Carly GK Ziegler, Swetha Ramakrishnan, Aneesah Polnett, Kelly Hamby, Taylor Deane, Linda Stempora, Bruce R. Blazar, MD, Leslie S. Kean, MD, PhD

Blood (2012) 120 (21): 1888.

https://doi.org/10.1182/blood.V120.21.1888.1888

Published: 2012

Journal Articles

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

Ran Reshef, MD, Selina M. Luger, MD, Elizabeth O. Hexner, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Sunita D. Nasta, MD, Edward A. Stadtmauer, MD, Jacqueline Smith, CRNP, Rosemarie Mick, MS, Daniel F. Heitjan, PhD, James A. Hoxie, MD, Stephen G. Emerson, MD, PhD, Robert H. Vonderheide, MD, PhD, David L. Porter, MD

Blood (2011) 118 (21): 1011.

https://doi.org/10.1182/blood.V118.21.1011.1011

Published: 2011

Journal Articles

Reduced Intensity Conditioning with Fludarabine/Busulfan 6.4mg/Kg Results In High Donor Chimerism and Low Toxicity In Both Related and Unrelated Allo-SCT for Hematologic Malignancies.

Steven C Goldstein, MD, Selina M. Luger, MD, Noelle Frey, MD, Alexander Perl, MD, Edward A Stadtmauer, MD, Donald Tsai, MD, Alison Loren, MD, Sunita Nasta, MD, Elizabeth Hexner, MD, Ran Reshef, MD, Jacqueline Smith, CRNP, Joanne Hinkle, Pavel Vassilev, BS, Michael J Vozniak, PharmD, David L. Porter, MD

Blood (2010) 116 (21): 4519.

https://doi.org/10.1182/blood.V116.21.4519.4519

Published: 2010

Journal Articles

Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist

Ran Reshef, MD, Selina M. Luger, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Elizabeth O. Hexner, MD, Edward A. Stadtmauer, MD, Jacqueline Smith, CRNP, Rosemarie Mick, MS, Daniel F. Heitjan, PhD, Susan E. Shetzline, PhD, Gwenn-ael H. Danet-Desnoyers, PhD, Stephen G. Emerson, MD, PhD, James A. Hoxie, MD, Robert H. Vonderheide, MD, PhD, David L. Porter, MD

Blood (2010) 116 (21): 673.

https://doi.org/10.1182/blood.V116.21.673.673

Published: 2010

NARROW

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

CCL3 Signaling Is Essential for Leukemia Progression but Dispensable for Hematopoietic Stem Cell Maintenance

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

CCL5 derived from platelets increases megakaryocyte proplatelet formation

Platelets Promote Breast Cancer Metastasis By Reprogramming Tumor Cells to Produce IL-8

CCL5 Released from Platelets Increases Megakaryocyte Maturation and Proplatelet Formation

Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals

Response: maraviroc intensification and microbial translocation

The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial

Defining the Primate GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

Reduced Intensity Conditioning with Fludarabine/Busulfan 6.4mg/Kg Results In High Donor Chimerism and Low Toxicity In Both Related and Unrelated Allo-SCT for Hematologic Malignancies.

Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only